CNC vs CVS
Centene Corporation and CVS Health, both Healthcare
CVS Health is the larger company at $125B against $30B. Over the past year CNC returned +160% against +52% for CVS. Ryufin's sector-relative Smart Score puts CNC ahead, 8/10 against 6/10.
| Figure | CNC | CVS |
|---|---|---|
| Last close | $65.47 | $94.30 |
| Market cap | $30B | $125B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | n/a | 24.8 |
| Dividend yield | n/a | 2.8% |
| 1-year return | +160% | +52% |
| 5-year return | -4.6% | +34% |
| Ryufin Smart Scoresector-relative, 1–10 | 8/10 | 6/10 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Centene Corporation
Revenue of $54B in Q2 2026, net income $1.1B. Its largest reported line is Medicaid, 54% of the disclosed total.
CVS Health
Revenue of $106B in Q2 2026, net income $3.0B. Its largest reported line is Health Services, 42% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or read the correlation.